Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

1.

Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function.

Seubert JM, Sinal CJ, Graves J, DeGraff LM, Bradbury JA, Lee CR, Goralski K, Carey MA, Luria A, Newman JW, Hammock BD, Falck JR, Roberts H, Rockman HA, Murphy E, Zeldin DC.

Circ Res. 2006 Aug 18;99(4):442-50. Epub 2006 Jul 20.

PMID:
16857962
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Soluble epoxide hydrolase: gene structure, expression and deletion.

Harris TR, Hammock BD.

Gene. 2013 Sep 10;526(2):61-74. doi: 10.1016/j.gene.2013.05.008. Epub 2013 May 20. Review.

PMID:
23701967
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Arachidonic acid cytochrome P450 epoxygenase pathway.

Spector AA.

J Lipid Res. 2009 Apr;50 Suppl:S52-6. doi: 10.1194/jlr.R800038-JLR200. Epub 2008 Oct 23. Review.

PMID:
18952572
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Soluble epoxide hydrolase and ischemic cardiomyopathy.

Zhao TT, Wasti B, Xu DY, Shen L, Du JQ, Zhao SP.

Int J Cardiol. 2012 Mar 8;155(2):181-7. doi: 10.1016/j.ijcard.2011.05.067. Epub 2011 Jun 24. Review.

PMID:
21704394
[PubMed - indexed for MEDLINE]
5.

Soluble epoxide hydrolase: a new target for cardioprotection.

Gross GJ, Nithipatikom K.

Curr Opin Investig Drugs. 2009 Mar;10(3):253-8. Review.

PMID:
19333883
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Epoxyeicosatrienoic acid pathway in human health and diseases.

Bellien J, Joannides R.

J Cardiovasc Pharmacol. 2013 Mar;61(3):188-96. doi: 10.1097/FJC.0b013e318273b007. Review.

PMID:
23011468
[PubMed - indexed for MEDLINE]
7.

Soluble epoxide hydrolase: a novel target for the treatment of hypertension.

Fang X.

Recent Pat Cardiovasc Drug Discov. 2006 Jan;1(1):67-72. Review.

PMID:
18221075
[PubMed - indexed for MEDLINE]
8.

Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation.

Deng Y, Theken KN, Lee CR.

J Mol Cell Cardiol. 2010 Feb;48(2):331-41. doi: 10.1016/j.yjmcc.2009.10.022. Epub 2009 Nov 3. Review.

PMID:
19891972
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Action of epoxyeicosatrienoic acids on cellular function.

Spector AA, Norris AW.

Am J Physiol Cell Physiol. 2007 Mar;292(3):C996-1012. Epub 2006 Sep 20. Review.

PMID:
16987999
[PubMed - indexed for MEDLINE]
Free Article
10.

Soluble epoxide hydrolase in atherosclerosis.

Wang YX, Ulu A, Zhang LN, Hammock B.

Curr Atheroscler Rep. 2010 May;12(3):174-83. doi: 10.1007/s11883-010-0108-5. Review.

PMID:
20425256
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases.

Duflot T, Roche C, Lamoureux F, Guerrot D, Bellien J.

Expert Opin Drug Discov. 2014 Mar;9(3):229-43. doi: 10.1517/17460441.2014.881354. Epub 2014 Feb 4. Review.

PMID:
24490654
[PubMed - indexed for MEDLINE]
12.

Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer.

Zhang G, Kodani S, Hammock BD.

Prog Lipid Res. 2014 Jan;53:108-23. doi: 10.1016/j.plipres.2013.11.003. Epub 2013 Dec 15. Review.

PMID:
24345640
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk